Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 21, 2005; 11(35): 5455-5459
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5455
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5455
Figure 3 Effect of VEGF knockdown in a tumor grafted mouse ascites model.
A: The ascites volume of mice inoculated with VEGF-KD7 or VEGF-WT cells (n = 5, P = 0.10, mean±SD); B: The VEGF concentration in ascites. VEGF in the ascites was measured using ELISA (n = 4, P = 0.054, mean±SD). C: 1106 VEGF-KD7 or VEGF-WT cells were inoculated into mice intraperitoneally and the mice were weighed (n = 8, P≥0.05 in each data point).
- Citation: Guleng B, Tateishi K, Kanai F, Jazag A, Ohta M, Asaoka Y, Ijichi H, Tanaka Y, Imamura J, Ikenoue T, Fukushima Y, Morikane K, Miyagishi M, Taira K, Kawabe T, Omata M. Cancer-derived VEGF plays no role in malignant ascites formation in the mouse. World J Gastroenterol 2005; 11(35): 5455-5459
- URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5455.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i35.5455